Expression and regulation of the Escherichia coli O157:H7 effector proteins NleH1 and NleH2.

PubWeight™: 0.81‹?›

🔗 View Article (PMC 3299786)

Published in PLoS One on March 12, 2012

Authors

Ashleigh Holmes1, Cecilia S Lindestam Arlehamn, Dai Wang, Tim J Mitchell, Tom J Evans, Andrew J Roe

Author Affiliations

1: Institute of Infection, Immunity and Inflammation, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom.

Articles cited by this

Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J Gen Virol (1977) 41.93

Analysis of gene control signals by DNA fusion and cloning in Escherichia coli. J Mol Biol (1980) 41.18

Construction of Escherichia coli K-12 in-frame, single-gene knockout mutants: the Keio collection. Mol Syst Biol (2006) 40.15

Genome sequence of enterohaemorrhagic Escherichia coli O157:H7. Nature (2001) 23.49

Enteropathogenic E. coli (EPEC) transfers its receptor for intimate adherence into mammalian cells. Cell (1997) 9.60

Dissecting virulence: systematic and functional analyses of a pathogenicity island. Proc Natl Acad Sci U S A (2004) 5.34

Citrobacter rodentium of mice and man. Cell Microbiol (2005) 4.76

An extensive repertoire of type III secretion effectors in Escherichia coli O157 and the role of lambdoid phages in their dissemination. Proc Natl Acad Sci U S A (2006) 3.89

Quorum sensing Escherichia coli regulators B and C (QseBC): a novel two-component regulatory system involved in the regulation of flagella and motility by quorum sensing in E. coli. Mol Microbiol (2002) 3.48

The locus of enterocyte effacement (LEE)-encoded regulator controls expression of both LEE- and non-LEE-encoded virulence factors in enteropathogenic and enterohemorrhagic Escherichia coli. Infect Immun (2000) 3.20

The Shigella flexneri effector OspG interferes with innate immune responses by targeting ubiquitin-conjugating enzymes. Proc Natl Acad Sci U S A (2005) 2.88

The flagella of enteropathogenic Escherichia coli mediate adherence to epithelial cells. Mol Microbiol (2002) 2.75

Identification and characterization of NleA, a non-LEE-encoded type III translocated virulence factor of enterohaemorrhagic Escherichia coli O157:H7. Mol Microbiol (2004) 2.51

Enteropathogenic Escherichia coli: unravelling pathogenesis. FEMS Microbiol Rev (2005) 2.49

Ribosomal protein S3: a KH domain subunit in NF-kappaB complexes that mediates selective gene regulation. Cell (2007) 2.46

Transcriptional regulation of type III secretion genes in enteropathogenic Escherichia coli: Ler antagonizes H-NS-dependent repression. Mol Microbiol (2001) 2.43

Identification of Escherichia coli O157 : H7 genes influencing colonization of the bovine gastrointestinal tract using signature-tagged mutagenesis. Microbiology (2004) 2.25

Enteropathogenic and enterohemorrhagic Escherichia coli virulence gene regulation. Infect Immun (2007) 2.18

Invasive Shigella flexneri activates NF-kappa B through a lipopolysaccharide-dependent innate intracellular response and leads to IL-8 expression in epithelial cells. J Immunol (2000) 2.05

Essential role of the type III secretion system effector NleB in colonization of mice by Citrobacter rodentium. Infect Immun (2006) 2.01

Enteropathogenic and enterohaemorrhagic Escherichia coli deliver a novel effector called Cif, which blocks cell cycle G2/M transition. Mol Microbiol (2003) 1.96

A positive regulatory loop controls expression of the locus of enterocyte effacement-encoded regulators Ler and GrlA. J Bacteriol (2005) 1.77

Positive effects of multiple pch genes on expression of the locus of enterocyte effacement genes and adherence of enterohaemorrhagic Escherichia coli O157 : H7 to HEp-2 cells. Microbiology (2004) 1.70

Bacterial effector binding to ribosomal protein s3 subverts NF-kappaB function. PLoS Pathog (2009) 1.61

Transcriptional regulation of the esp genes of enterohemorrhagic Escherichia coli. J Bacteriol (1999) 1.53

Identification of enterohemorrhagic Escherichia coli O26:H- genes required for intestinal colonization in calves. Infect Immun (2005) 1.52

Regulation of type III secretion hierarchy of translocators and effectors in attaching and effacing bacterial pathogens. Infect Immun (2005) 1.51

Analysis of fimbrial gene clusters and their expression in enterohaemorrhagic Escherichia coli O157:H7. Environ Microbiol (2006) 1.51

NleH effectors interact with Bax inhibitor-1 to block apoptosis during enteropathogenic Escherichia coli infection. Proc Natl Acad Sci U S A (2010) 1.43

Heterogeneous surface expression of EspA translocon filaments by Escherichia coli O157:H7 is controlled at the posttranscriptional level. Infect Immun (2003) 1.41

An investigation of the expression and adhesin function of H7 flagella in the interaction of Escherichia coli O157 : H7 with bovine intestinal epithelium. Cell Microbiol (2008) 1.37

Global regulation by horizontally transferred regulators establishes the pathogenicity of Escherichia coli. DNA Res (2008) 1.27

IKKβ phosphorylation regulates RPS3 nuclear translocation and NF-κB function during infection with Escherichia coli strain O157:H7. Nat Immunol (2011) 1.26

Citrobacter rodentium virulence in mice associates with bacterial load and the type III effector NleE. Microbes Infect (2007) 1.19

Increased adherence to Caco-2 cells caused by disruption of the yhiE and yhiF genes in enterohemorrhagic Escherichia coli O157:H7. Infect Immun (2003) 1.18

Enteropathogenic E. coli non-LEE encoded effectors NleH1 and NleH2 attenuate NF-κB activation. Mol Microbiol (2010) 1.18

The LEE1 promoters from both enteropathogenic and enterohemorrhagic Escherichia coli can be activated by PerC-like proteins from either organism. J Bacteriol (2005) 1.15

The bacterial virulence factor NleA is required for the disruption of intestinal tight junctions by enteropathogenic Escherichia coli. Cell Microbiol (2009) 1.14

Co-ordinate single-cell expression of LEE4- and LEE5-encoded proteins of Escherichia coli O157:H7. Mol Microbiol (2004) 1.13

A comprehensive proteomic analysis of the type III secretome of Citrobacter rodentium. J Biol Chem (2009) 1.13

Concert of regulators to switch on LEE expression in enterohemorrhagic Escherichia coli O157:H7: interplay between Ler, GrlA, HNS and RpoS. Int J Med Microbiol (2006) 1.12

Regulation of expression and secretion of NleH, a new non-locus of enterocyte effacement-encoded effector in Citrobacter rodentium. J Bacteriol (2008) 1.10

Regulation, secretion and activity of type III-secreted proteins of enterohaemorrhagic Escherichia coli O157. Biochem Soc Trans (2003) 1.09

Transcriptome of enterohemorrhagic Escherichia coli O157 adhering to eukaryotic plasma membranes. Infect Immun (2004) 1.08

Identification and characterization of EspK, a type III secreted effector protein of enterohaemorrhagic Escherichia coli O157:H7. FEMS Microbiol Lett (2006) 1.03

Transcriptional regulators of the GAD acid stress island are carried by effector protein-encoding prophages and indirectly control type III secretion in enterohemorrhagic Escherichia coli O157:H7. Mol Microbiol (2011) 1.02

Analysis of the expression, regulation and export of NleA-E in Escherichia coli O157 : H7. Microbiology (2007) 1.02

Role of NleH, a type III secreted effector from attaching and effacing pathogens, in colonization of the bovine, ovine, and murine gut. Infect Immun (2008) 1.02

GrlA of enterohemorrhagic Escherichia coli O157:H7 activates LEE1 by binding to the promoter region. J Microbiol Immunol Infect (2008) 0.92

Characterization of the NleF effector protein from attaching and effacing bacterial pathogens. FEMS Microbiol Lett (2008) 0.91

Structure of GrlR and the implication of its EDED motif in mediating the regulation of type III secretion system in EHEC. PLoS Pathog (2007) 0.90

Identification of a novel prophage regulator in Escherichia coli controlling the expression of type III secretion. Mol Microbiol (2011) 0.83

Regulation of nleA in Shiga toxin-producing Escherichia coli O84:H4 strain 4795/97. J Bacteriol (2010) 0.81

Articles by these authors

Identification of proteins in human cytomegalovirus (HCMV) particles: the HCMV proteome. J Virol (2004) 4.30

Structure and dynamics of the pan-genome of Streptococcus pneumoniae and closely related species. Genome Biol (2010) 2.60

Role of conjugative elements in the evolution of the multidrug-resistant pandemic clone Streptococcus pneumoniaeSpain23F ST81. J Bacteriol (2008) 2.51

Pneumococcal pneumolysin and H(2)O(2) mediate brain cell apoptosis during meningitis. J Clin Invest (2002) 2.50

Application of an iterative Bayesian variable selection method in a genome-wide association study of rheumatoid arthritis. BMC Proc (2007) 2.43

Competence-programmed predation of noncompetent cells in the human pathogen Streptococcus pneumoniae: genetic requirements. Proc Natl Acad Sci U S A (2005) 2.24

A novel NOD2/CARD15 haplotype conferring risk for Crohn disease in Ashkenazi Jews. Am J Hum Genet (2003) 2.17

Longitudinal data analysis in pedigree studies. Genet Epidemiol (2003) 2.06

Serum immunoglobulin G response to candidate vaccine antigens during experimental human pneumococcal colonization. Infect Immun (2003) 1.83

Human mitochondrial transcription factor B1 as a modifier gene for hearing loss associated with the mitochondrial A1555G mutation. Mol Genet Metab (2004) 1.81

Salmonella transforms follicle-associated epithelial cells into M cells to promote intestinal invasion. Cell Host Microbe (2012) 1.78

IL-23 receptor (IL-23R) gene protects against pediatric Crohn's disease. Inflamm Bowel Dis (2007) 1.71

Variation in the 3-hydroxyl-3-methylglutaryl coenzyme a reductase gene is associated with racial differences in low-density lipoprotein cholesterol response to simvastatin treatment. Circulation (2008) 1.68

A comparison of enteropathogenic and enterohaemorrhagic Escherichia coli pathogenesis. FEMS Microbiol Lett (2006) 1.64

Role of inflammatory mediators in resistance and susceptibility to pneumococcal infection. Infect Immun (2002) 1.59

Escherichia coli O157 : H7 forms attaching and effacing lesions at the terminal rectum of cattle and colonization requires the LEE4 operon. Microbiology (2005) 1.56

The VP1 N-terminal sequence of canine parvovirus affects nuclear transport of capsids and efficient cell infection. J Virol (2002) 1.52

Analysis of fimbrial gene clusters and their expression in enterohaemorrhagic Escherichia coli O157:H7. Environ Microbiol (2006) 1.51

Upper and lower respiratory tract infection by Streptococcus pneumoniae is affected by pneumolysin deficiency and differences in capsule type. Infect Immun (2002) 1.50

Regulators encoded in the Escherichia coli type III secretion system 2 gene cluster influence expression of genes within the locus for enterocyte effacement in enterohemorrhagic E. coli O157:H7. Infect Immun (2004) 1.49

The surface-anchored NanA protein promotes pneumococcal brain endothelial cell invasion. J Exp Med (2009) 1.48

Role of HtrA in the virulence and competence of Streptococcus pneumoniae. Infect Immun (2004) 1.40

The role of Streptococcus pneumoniae sortase A in colonisation and pathogenesis. Microbes Infect (2005) 1.37

Mutation of toxB and a truncated version of the efa-1 gene in Escherichia coli O157:H7 influences the expression and secretion of locus of enterocyte effacement-encoded proteins but not intestinal colonization in calves or sheep. Infect Immun (2004) 1.35

Reactive oxygen species regulate neutrophil recruitment and survival in pneumococcal pneumonia. Am J Respir Crit Care Med (2008) 1.33

Nitric oxide levels regulate macrophage commitment to apoptosis or necrosis during pneumococcal infection. FASEB J (2004) 1.33

Detection of large numbers of pneumococcal virulence genes in streptococci of the mitis group. J Clin Microbiol (2010) 1.32

Construction and immunological characterization of a novel nontoxic protective pneumolysin mutant for use in future pneumococcal vaccines. Infect Immun (2006) 1.32

Low CD4 T cell immunity to pneumolysin is associated with nasopharyngeal carriage of pneumococci in children. J Infect Dis (2007) 1.31

Pneumococcal behavior and host responses during bronchopneumonia are affected differently by the cytolytic and complement-activating activities of pneumolysin. Infect Immun (2003) 1.30

The role of potassium in inflammasome activation by bacteria. J Biol Chem (2010) 1.29

Streptococcus pneumoniae-associated human macrophage apoptosis after bacterial internalization via complement and Fcgamma receptors correlates with intracellular bacterial load. J Infect Dis (2003) 1.28

Spinocerebellar ataxia type 2: polyQ repeat variation in the CACNA1A calcium channel modifies age of onset. Brain (2005) 1.28

Genomic diversity between strains of the same serotype and multilocus sequence type among pneumococcal clinical isolates. Infect Immun (2006) 1.27

Direct and indirect transcriptional activation of virulence genes by an AraC-like protein, PerA from enteropathogenic Escherichia coli. Mol Microbiol (2004) 1.23

Contribution of a response regulator to the virulence of Streptococcus pneumoniae is strain dependent. Infect Immun (2003) 1.23

Control of virulence by the two-component system CiaR/H is mediated via HtrA, a major virulence factor of Streptococcus pneumoniae. J Bacteriol (2004) 1.23

Transcriptional regulation, occurrence and putative role of the Pht family of Streptococcus pneumoniae. Microbiology (2010) 1.19

Identification of invasive serotype 1 pneumococcal isolates that express nonhemolytic pneumolysin. J Clin Microbiol (2006) 1.18

Dominant role of nucleotide substitution in the diversification of serotype 3 pneumococci over decades and during a single infection. PLoS Genet (2013) 1.17

Presence of nonhemolytic pneumolysin in serotypes of Streptococcus pneumoniae associated with disease outbreaks. J Infect Dis (2007) 1.16

Identification of bacterial target proteins for the salicylidene acylhydrazide class of virulence-blocking compounds. J Biol Chem (2011) 1.15

Innate immune defense against pneumococcal pneumonia requires pulmonary complement component C3. Infect Immun (2005) 1.14

Identification of a detrimental role for NK cells in pneumococcal pneumonia and sepsis in immunocompromised hosts. Microbes Infect (2005) 1.14

Eukaryotic localization, activation and ubiquitinylation of a bacterial type III secreted toxin. Cell Microbiol (2006) 1.13

Pentameric complex of viral glycoprotein H is the primary target for potent neutralization by a human cytomegalovirus vaccine. Proc Natl Acad Sci U S A (2013) 1.12

Controlling injection: regulation of type III secretion in enterohaemorrhagic Escherichia coli. Trends Microbiol (2009) 1.10

Regulation of gene expression in Streptococcus pneumoniae by response regulator 09 is strain dependent. J Bacteriol (2006) 1.10

Hierarchal type III secretion of translocators and effectors from Escherichia coli O157:H7 requires the carboxy terminus of SepL that binds to Tir. Mol Microbiol (2008) 1.10

Increased adherence and actin pedestal formation by dam-deficient enterohaemorrhagic Escherichia coli O157:H7. Mol Microbiol (2007) 1.09

Previously undescribed grass pollen antigens are the major inducers of T helper 2 cytokine-producing T cells in allergic individuals. Proc Natl Acad Sci U S A (2013) 1.09

The EspF effector, a bacterial pathogen's Swiss army knife. Infect Immun (2010) 1.08

Pneumococci induced TLR- and Rac1-dependent NF-kappaB-recruitment to the IL-8 promoter in lung epithelial cells. Am J Physiol Lung Cell Mol Physiol (2005) 1.08

Pneumolysin causes neuronal cell death through mitochondrial damage. Infect Immun (2007) 1.07

Demonstration of regulatory cross-talk between P fimbriae and type 1 fimbriae in uropathogenic Escherichia coli. Microbiology (2006) 1.07

Contribution of the ATP-dependent protease ClpCP to the autolysis and virulence of Streptococcus pneumoniae. Infect Immun (2005) 1.06

Isolation and characterization of a new plasmid pSpnP1 from a multidrug-resistant clone of Streptococcus pneumoniae. Plasmid (2007) 1.05

What is different about serotype 1 pneumococci? Future Microbiol (2012) 1.04

Comparative genomic analysis of ten Streptococcus pneumoniae temperate bacteriophages. J Bacteriol (2009) 1.04

PclA, a pneumococcal collagen-like protein with selected strain distribution, contributes to adherence and invasion of host cells. FEMS Microbiol Lett (2008) 1.04

Human cytomegalovirus suppresses type I interferon secretion by plasmacytoid dendritic cells through its interleukin 10 homolog. Virology (2009) 1.04

Natural antibodies against several pneumococcal virulence proteins in children during the pre-pneumococcal-vaccine era: the generation R study. Infect Immun (2011) 1.03

The contribution of PspC to pneumococcal virulence varies between strains and is accomplished by both complement evasion and complement-independent mechanisms. Infect Immun (2006) 1.03

Transcriptional regulators of the GAD acid stress island are carried by effector protein-encoding prophages and indirectly control type III secretion in enterohemorrhagic Escherichia coli O157:H7. Mol Microbiol (2011) 1.02

Analysis of the expression, regulation and export of NleA-E in Escherichia coli O157 : H7. Microbiology (2007) 1.02

Phenotype of non-syndromic deafness associated with the mitochondrial A1555G mutation is modulated by mitochondrial RNA modifying enzymes MTO1 and GTPBP3. Mol Genet Metab (2004) 1.01

Innate immunity and the pneumococcus. Microbiology (2006) 1.01

Effects of cigarette smoke condensate on pneumococcal biofilm formation and pneumolysin. Eur Respir J (2012) 1.01

Prospective-retrospective biomarker analysis for regulatory consideration: white paper from the industry pharmacogenomics working group. Pharmacogenomics (2011) 0.99

Characterization of the effects of salicylidene acylhydrazide compounds on type III secretion in Escherichia coli O157:H7. Infect Immun (2009) 0.99

Development of a prophage typing system and analysis of prophage carriage in Streptococcus pneumoniae. Appl Environ Microbiol (2009) 0.98

Activation of brain endothelium by pneumococcal neuraminidase NanA promotes bacterial internalization. Cell Microbiol (2010) 0.98

Restoration of viral epithelial tropism improves immunogenicity in rabbits and rhesus macaques for a whole virion vaccine of human cytomegalovirus. Vaccine (2012) 0.97

Association between angiotensinogen, angiotensin II receptor genes, and blood pressure response to an angiotensin-converting enzyme inhibitor. Circulation (2007) 0.97

Gene responsible for mitochondrial myopathy and sideroblastic anemia (MSA) maps to chromosome 12q24.33. Am J Med Genet A (2004) 0.97

Induction of CC and CXC chemokines in human antigen-presenting dendritic cells by the pneumococcal proteins pneumolysin and CbpA, and the role played by toll-like receptor 4, NF-kappaB, and mitogen-activated protein kinases. J Infect Dis (2008) 0.96

Novel mucosal vaccines generated by genetic conjugation of heterologous proteins to pneumolysin (PLY) from Streptococcus pneumoniae. Vaccine (2010) 0.96

Crystal structure of the C-terminal region of Streptococcus mutans antigen I/II and characterization of salivary agglutinin adherence domains. J Biol Chem (2011) 0.96

Myxovirus-1 and protein kinase haplotypes and fibrosis in chronic hepatitis C virus. Hepatology (2007) 0.95

LOV to BLUF: flavoprotein contributions to the optogenetic toolkit. Mol Plant (2012) 0.95

Pseudomonas aeruginosa pilin activates the inflammasome. Cell Microbiol (2010) 0.94

Streptococcus pneumoniae-induced caspase 6-dependent apoptosis in lung epithelium. Infect Immun (2004) 0.94

Identification of a secreted cholesterol-dependent cytolysin (mitilysin) from Streptococcus mitis. J Bacteriol (2006) 0.93

Nitric oxide exerts distinct effects in local and systemic infections with Streptococcus pneumoniae. Microb Pathog (2004) 0.92

MAGI1 copy number variation in bipolar affective disorder and schizophrenia. Biol Psychiatry (2012) 0.92

Generation of gene deletions and gene replacements in Escherichia coli O157:H7 using a temperature sensitive allelic exchange system. Biol Proced Online (2006) 0.91

Mucosal antibody responses of colonized cattle to Escherichia coli O157-secreted proteins, flagellin, outer membrane proteins and lipopolysaccharide. FEMS Immunol Med Microbiol (2007) 0.90

Lysogeny with Shiga toxin 2-encoding bacteriophages represses type III secretion in enterohemorrhagic Escherichia coli. PLoS Pathog (2012) 0.90

Genetic effects on obesity assessed by bivariate genome scan: the Mexican-American coronary artery disease study. Obesity (Silver Spring) (2006) 0.89

Expression, purification, crystallization and initial X-ray diffraction analysis of thiol peroxidase from Yersinia pseudotuberculosis. Acta Crystallogr Sect F Struct Biol Cryst Commun (2010) 0.89

Immunisation with anthrolysin O or a genetic toxoid protects against challenge with the toxin but not against Bacillus anthracis. Vaccine (2007) 0.88

Effects of the type III secreted pseudomonal toxin ExoS in the yeast Saccharomyces cerevisiae. Microbiology (2006) 0.88

Inhibition of HTLV-1 transcription by cyclin dependent kinase inhibitors. Mol Cell Biochem (2002) 0.88

Rapidly building global health security capacity--Uganda demonstration project, 2013. MMWR Morb Mortal Wkly Rep (2014) 0.88